Combination of immune checkpoint blockade and targeted gene regulation of angiogenesis for facilitating antitumor immunotherapy

The rapid development of tumor immunotherapy has improved the management of patients with cancer. However, several key problems of tumor immunotherapy, including the insufficient activation of effector T cells, poor tumor invasion, and poor immune killing ability, lead to a low response rate. In the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhan, Jing, Zhang, Manli, Zhou, Lili, He, Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040836/
https://www.ncbi.nlm.nih.gov/pubmed/36994358
http://dx.doi.org/10.3389/fbioe.2023.1065773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040836/
https://www.ncbi.nlm.nih.gov/pubmed/36994358
http://dx.doi.org/10.3389/fbioe.2023.1065773

Ejemplares similares